VEGA
STRONG BUYVEGA, the technology consultant backed by Growth Company Investor at 186.5p, continues to delight with bullish news flow – chief executive Phil Cartmell has just announced new business with the European Space Agency worth €2m (£1.38m).
The company has been awarded a new two year work package, with a potential two year extension, to provide support and maintenance for a range of software applications used by the European Space Agency for spacecraft missions flown from its operations centre in Germany. The work, which falls within a framework contract announced by the group last month, is worth at least €2m over four years, and VEGA successfully beat off three other consortia to secure the work.
VEGA recently cheered investors with strong half-time figures to October that revealed bumper sales growth in each region and market sector. Now firmly focused on the aerospace, defence and government markets, VEGA reported a 20% pre-tax profit leap to £2m on sales up 25% to £30.6m. Cartmell also flagged up healthy organic growth of 20%, and said VEGA was off to a flyer in the second half-year.
City forecasts for the year – before this most recent European Space Agency news – suggested profits of £4.6m and earnings of 15.2p, which would place the shares on an undemanding prospective p/e ratio of 13.3. Investors can expect further upbeat news from this stellar performer. We remain strong buyers at the current price.
- Reduce text size Decrease text size
- Increase text size Increase text size
- Print article Print
- Share this article Share
- Email article to a friend Email
Market cap: £37.5m
PE Forecast: 13.3
Share price: 202.5p
Subscribe today
More breaking news stories.
More extended feature articles.
And a depth of analysis you
can't find anywhere else.
Advertisement
VCT Report 2010
VCT Report 2010 uncovers the money available
for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted
company.
Order VCT Report 2010 today using this online form
Cash Shells Directory 2010
A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.
Coverage of AIM, techMARK and PLUS Markets
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
Take control of your investments
A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.
The Financial Times Guide to Personal Tax
is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.
The AIM Guide Spring 2010
The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).
A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!
Share recommendations and small-cap stock picks
Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.
Popular Recommendations
Advertisement
Latest Recommendations
Delcam 01/09/2010
Delcam, the international seller of CAD/CAM software to the engineering, aerospace and healthcare sectors among others, is a cash-generative small-cap seeing recovery in its markets.
Antisoma 01/09/2010
Bombed-out biotech play Antisoma is hoping two of its drugs will lead to good fortune after experiencing disaster with lung cancer treatment ASA404.
The Capital Pub Company 31/08/2010
London pub operator The Capital Pub Company is seeing continuing sales growth on the back of a surprisingly resilient market.
Sectors
